SHINE Medical eyeing Mo-99 production facility in Europe

Wisconsin's SHINE Medical Technologies LLC, the nuclear medicine company that's currently building a facility in Janesville for its production of a radioisotope used in medical imaging, is planning to build a similar facility on a yet-to-be-determined site in Europe. SHINE's Janesville facility is for the commercial production of molybdenum-99, or Mo-99, which decays into technetium‑99m used in more than 40 million medical imaging procedures each year. The facility is expected to be completed…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news